- The worldwide
market for therapeutic and diagnostic monoclonal antibodies is
expected to reach $26 million (€21.2 million) by 2010, buoyed on by
technological advances that allow antibodies to exhibit a specified
targeted attack on disease-causing cells or compounds.
- Revenue from
antibodies for therapeutic and diagnostic uses is expected to grow
at an average annual growth rate of 11.5%, according to a 2005
report, “Dynamic Antibody Industry,” published by the Business
Communications Company. With an estimated market of $15 billion in
2005, revenues should reach $26 billion by 2010.
- In response to
market demands for an alternative method, SDI has developed an
antigen expression method that removes antigen development and
production work from the researcher’s laboratory. An additional
benefit to moving antigen development and production to SDI is the
consistency and reliability of a highly robust system.
want the information on "Technology,
Market, Production, Conjugation, Purification, Company Profiles,
can email us to